Innovent Biologics
(OTC) IVBXF
Innovent Biologics Financials at a Glance
Market Cap
$19.22B
Revenue (TTM)
CN¥22.35B
Net Income (TTM)
CN¥719.28M
EPS (TTM)
$0.07
P/E Ratio
161.93
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Price
$11.06
Volume
361
Open
$9.89
Price
$11.06
Volume
361
Open
$9.89
Previous Close
$11.06
Daily Range
$9.89 - $11.06
52-Week Range
$9.10 - $15.12
Estimated Earnings Date
Aug 26, 2026
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Price
$11.06
Volume
361
Open
$9.89
Previous Close
$11.06
Daily Range
$9.89 - $11.06
52-Week Range
$9.10 - $15.12
Estimated Earnings Date
Aug 26, 2026
IVBXF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Innovent Biologics
Industry
Biotechnology
Sector
Health CareEmployees
7,502
CEO
De Chao Yu, PhD
Website
www.innoventbio.comHeadquarters
Suzhou, 215123, CN
IVBXF Financials
Key Financial Metrics (TTM)
Gross Margin
76.42%
Operating Margin
5.63%
Net Income Margin
6.24%
Return on Equity
4.82%
Return on Capital
8.88%
Return on Assets
2.18%
Earnings Yield
0.62%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$19.22B
Shares Outstanding
1.74B
Volume
361
Avg. Volume
5.45K
Financials (TTM)
Gross Profit
CN¥17.67B
Operating Income
CN¥733.33M
EBITDA
CN¥1.59B
Operating Cash Flow
CN¥11.26B
Capital Expenditure
-CN¥1.30B
Free Cash Flow
CN¥9.97B
Cash & ST Invst.
CN¥18.24B
Total Debt
CN¥2.82B
Innovent Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CN¥6.97B
+98.9%
Gross Profit
CN¥6.06B
+144.5%
Gross Margin
86.98%
N/A
Market Cap
$19.22B
N/A
Market Cap/Employee
$3.40M
N/A
Employees
5,659
N/A
Net Income
-CN¥20.41M
+97.7%
EBITDA
CN¥1.05B
+240.9%
Quarterly Fundamentals
Total Cash
CN¥18.24B
+66.3%
Total Debt
CN¥2.82B
-22.2%
Accounts Receivable
CN¥1.75B
+74.2%
Inventory
CN¥1.30B
+34.5%
Long Term Debt
CN¥2.02B
-16.0%
Short Term Debt
CN¥811.63M
-33.5%
Return on Assets
2.18%
N/A
Return on Invested Capital
2.53%
N/A
Free Cash Flow
CN¥9.43B
+3685.2%
Operating Cash Flow
CN¥9.66B
+1153.6%